Madison Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$49.8M Sell
54,134
-6,780
-11% -$6.87M 0.62% 58
2025
Q4
$65.5M Buy
60,914
+2,058
+3% +$1.97M 0.75% 49
2025
Q3
$44.9M Buy
58,856
+3,168
+6% +$2.36M 0.5% 61
2025
Q2
$43.4M Buy
55,688
+6,193
+13% +$4.81M 0.47% 61
2025
Q1
$40.9M Sell
49,495
-153
-0.3% -$127K 0.46% 67
2024
Q4
$38.3M Sell
49,648
-378
-0.8% -$313K 0.43% 68
2024
Q3
$44.3M Sell
50,026
-628
-1% -$565K 0.5% 65
2024
Q2
$45.9M Sell
50,654
-331
-0.6% -$265K 0.57% 59
2024
Q1
$39.7M Buy
50,985
+18
+0% +$12.8K 0.49% 60
2023
Q4
$29.7M Sell
50,967
-1,432
-3% -$836K 0.4% 75
2023
Q3
$28.1M Sell
52,399
-1,006
-2% -$518K 0.41% 80
2023
Q2
$25M Sell
53,405
-1,413
-3% -$593K 0.37% 89
2023
Q1
$18.8M Sell
54,818
-34,976
-39% -$11.8M 0.29% 97
2022
Q4
$32.9M Buy
89,794
+408
+0.5% +$145K 0.52% 67
2022
Q3
$28.9M Buy
89,386
+1,009
+1% +$320K 0.49% 76
2022
Q2
$28.7M Buy
88,377
+24,155
+38% +$7.25M 0.45% 84
2022
Q1
$18.4M Buy
64,222
+4,051
+7% +$1.04M 0.26% 105
2021
Q4
$16.6M Sell
60,171
-1,685
-3% -$427K 0.22% 111
2021
Q3
$14.3M Buy
61,856
+1,136
+2% +$280K 0.2% 114
2021
Q2
$13.9M Buy
60,720
+3,093
+5% +$621K 0.19% 120
2021
Q1
$10.8M Buy
57,627
+1,112
+2% +$218K 0.15% 125
2020
Q4
$9.54M Buy
56,515
+5,315
+10% +$794K 0.14% 123
2020
Q3
$7.58M Buy
51,200
+845
+2% +$131K 0.13% 124
2020
Q2
$8.27M Buy
50,355
+1,448
+3% +$222K 0.15% 121
2020
Q1
$6.78M Buy
48,907
+251
+0.5% +$34.5K 0.14% 124
2019
Q4
$6.39M Buy
+48,656
New +$5.64M 0.1% 167

Other funds holding LLY

Madison Asset Management's LLY Position: Q1 2026 in Review

Madison Asset Management reduced its Eli Lilly (LLY) stake by 11% in Q1 2026, selling an estimated $6.87M and leaving 54,134 shares worth $49.8M. The position accounts for 0.62% of the portfolio, ranked #58.

Madison Asset Management first reported a position in LLY in Q4 2019 and has held it in 26 quarters since. The position peaked at $65.5M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Madison Asset Management held 54,134 shares of Eli Lilly worth $49.8M as of Q1 2026.
  • Madison Asset Management sold 6,780 Eli Lilly shares in Q1 2026, an estimated $6.87M.
  • Eli Lilly made up 0.62% of Madison Asset Management's portfolio in Q1 2026, its #58 holding.
  • Madison Asset Management first reported a position in Eli Lilly in Q4 2019 and has held it in 26 quarters since.
  • Madison Asset Management's Eli Lilly position peaked at $65.5M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Madison Asset Management's 13F filing for Q1 2026, filed 7 May 2026.